The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Airway Microbiome Dynamics in Exacerbations of Chronic Obstructive Pulmonary Disease
Open accessAbstract
Specific bacterial species are implicated in the pathogenesis of exacerbations of chronic obstructive pulmonary disease (COPD). However, recent studies of clinically stable COPD patients have demonstrated a greater diversity of airway microbiota, whose role in acute exacerbations is unclear. In this study, temporal changes in the airway microbiome before, at the onset of, and after an acute exacerbation were examined in 60 sputum samples collected from subjects enrolled in a longitudinal study of bacterial infection in COPD. Microbiome composition and predicted functions were examined using 16S rRNA-based culture-independent profiling methods. Shifts in the abundance (≥ 2-fold, P < 0.05) of many taxa at exacerbation and after treatment were observed. Microbiota members that were increased at exacerbation were primarily of the Proteobacteria phylum, including nontypical COPD pathogens. Changes in the bacterial composition after treatment for an exacerbation differed significantly among the therapy regimens clinically prescribed (antibiotics only, oral corticosteroids only, or both). Treatment with antibiotics alone primarily decreased the abundance of Proteobacteria, with the prolonged suppression of some microbiota members being observed. In contrast, treatment with corticosteroids alone led to enrichment for Proteobacteria and members of other phyla. Predicted metagenomes of particular microbiota members involved in these compositional shifts indicated exacerbation-associated loss of functions involved in the synthesis of antimicrobial and anti-inflammatory products, alongside enrichment in functions related to pathogen-elicited inflammation. These trends reversed upon clinical recovery. Further larger studies will be necessary to determine whether specific compositional or functional changes detected in the airway microbiome could be useful indicators of exacerbation development or outcome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With remarkable consistency, all studies report no increase in bacterial burden and no decrease in community diversity during exacerbations.”
From The microbiome and critical illness (2016) · cites this paper as [132]
Citations
Cites
vegan: Community Ecology Package
Oksanen, J., Simpson, G. L., Blanchet, F. G., Kindt, R., Legendre, P., Minchin, P. R., O’Hara, R. B., Sólymos, P., Stevens, M. H. H., Szöcs, E., et al. (2001) · doi:10.32614/cran.package.vegan · Cited by 27,099
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
A new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences
Langille, M. G. I., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes, J. A., Clemente, J. C., Burkepile, D. E., Vega Thurber, R. L., Knight, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2676 · Cited by 9,116
UniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227
PAUWELS, R. A., Buist, A. S., CALVERLEY, P. M. A., Jenkins, C. R., & Hurd, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,572
Picante: R tools for integrating phylogenies and ecology
Kembel, S. W., Cowan, P. D., Helmus, M. R., Cornwell, W. K., Morlon, H., Ackerly, D. D., Blomberg, S. P., & Webb, C. O. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq166 · Cited by 6,192
Conservation evaluation and phylogenetic diversity
Faith, D. (1992) · Biological Conservation · doi:10.1016/0006-3207(92)91201-3 · Cited by 5,495
Cited by
Sorted by citations
Items 201–300 of 322
Sapp, J. (2016) · Evolutionary Biology · doi:10.1007/s11692-016-9378-3 · Cited by 10
Shema Oral Liquid Ameliorates the Severity of LPS-Induced COPD via Regulating DNMT1
Zhang, F., Guo, F., Liu, Y., Zhang, Y., Li, D., & Yang, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.903593 · Cited by 9
Won, S. H., Kwon, Y. S., Yoon, S. H., Jung, C. Y., Kim, J., Choi, H. S., Sheen, S. S., Hwang, H.-G., Lee, J., & Kim, T. (2017) · The Clinical Respiratory Journal · doi:10.1111/crj.12671 · Cited by 9
Balancing Benefits and Risks: Do Inhaled Corticosteroids Modify the Lung Microbiome?
Singh, S., Pragman, A. A., & Segal, L. N. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202109-2024ed · Cited by 9
Abotsi, R. E., Dube, F. S., Rehman, A. M., Claassen-Weitz, S., Xia, Y., Simms, V. M., Mwaikono, K. S., Gardner‐Lubbe, S., McHugh, G., Ngwira, L. G., et al. (2023) · Microbiome · doi:10.1186/s40168-023-01460-x · Cited by 9
A succession of pulmonary microbiota in broilers during the growth cycle
Shen, D., Wang, K., Fathi, M. A., Li, Y., Win‐Shwe, T., & Li, C. (2023) · Poultry Science · doi:10.1016/j.psj.2023.102884 · Cited by 8
Pang, X., Huang, P. C., Huang, S., & Liu, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1657675 · Cited by 15
Rogers, G. B. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170043 · Cited by 8
Qiu, X., Bajinka, O., Wang, L., Wu, G., & Tan, Y. (2021) · PubMed Central · Cited by 8
Wu, X., Wei, X., Li, X., Deng, J., & Zhang, J. (2022) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2022.153 · Cited by 7
New insights into the pathophysiology and epidemiology of COPD exacerbations
Finney, L., MacLeod, M. A., & Wedzicha, J. A. (2024) · European Respiratory Society eBooks · doi:10.1183/2312508x.10007923 · Cited by 7
Hu, J. C., & Sethi, S. (2024) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2024.2396413 · Cited by 8
The Lung Microbiome in Health and Respiratory Diseases
Marimón, J. M. (2018) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000268 · Cited by 7
The Effects of Immunosuppression on the Lung Microbiome and Metabolites in Rats
Dong, H., Tan, R., Chen, Z., Wang, L., Song, Y., Jin, M., Yin, J., Li, H., Lǐ, J., & Yang, D. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.817159 · Cited by 7
Vaccination and modern management of chronic obstructive pulmonary disease – a narrative review
Joean, O., & Welte, T. (2022) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2022.2092099 · Cited by 6
Global Research Trends on the Link Between the Microbiome and COPD: A Bibliometric Analysis
Chen, D., Zeng, Q., Liu, L., Zhou, Z., Qi, W., Yu, S., & Zhao, L. (2023) · International Journal of COPD · doi:10.2147/copd.s405310 · Cited by 9
Agarwal, D. M., Dhotre, D. P., Patil, R., Shouche, Y. S., Juvekar, S. K., & Salvi, S. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00196 · Cited by 7
The Human Microbiome in the Lung: Are Infections Contributing to Lung Health and Disease?
Gates, K. L., & Martínez, F. J. (2016) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.3.1.2015.0174 · Cited by 7
Li, Y., Mao, X., Shi, P., Wan, Z., Yang, D., Ma, T., Wang, B., Wang, J., Wang, J., & Zhu, R. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1386201 · Cited by 6
Shi, Y., Yang, J., Tian, T., Li, S., & Xie, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1487393 · Cited by 7
Ding, P., Wang, X., Li, N., Yu, S., Zhang, Y., Yu, J., Tian, T., Chen, R., Luo, B., Ma, L., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1615130 · Cited by 6
Wang, Y., Li, X., & Gao, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1549865 · Cited by 7
Sempere, J., Yuste, J., & Domenech, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1495932 · Cited by 6
O’Farrell, H. E., Shaw, J. G., Goh, F., Bowman, R., Fong, K. M., Krause, L., & Yang, I. A. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.10.39 · Cited by 5
Thébault, J.-L., Roche, N., Abdoul, H., Lorenzo, A., Similowski, T., & Ghasarossian, C. (2023) · ERJ Open Research · doi:10.1183/23120541.00057-2023 · Cited by 7
Ma, N., Qi, Y.-J., Liang, X., Bai, J., Deng, J., Li, M., & He, Z. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.637246 · Cited by 6
Muggeo, A., Perotin, J., Brisebarre, A., Dury, S., Dormoy, V., Launois, C., Ancel, J., Mulette, P., de Champs, C., Deslée, G., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.781797 · Cited by 6
Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
Anzueto, A., Restrepo, M. I., & Sibila, O. (2017) · Barcelona Respiratory Network · doi:10.23866/brnrev:2017-0004 · Cited by 6
Beyond the organ: lung microbiome shapes transplant indications and outcomes
Ponholzer, F., Bogensperger, C., Krendl, F. J., Krapf, C., Dumfarth, J., Schneeberger, S., & Augustin, F. (2024) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezae338 · Cited by 5
Chen, M., Cui, Y., Liu, C., Tong, X., Wang, M., Wu, C., Liu, Y., Zhao, Y., & Chen, X. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-25528-1 · Cited by 5
Non-cystic fibrosis bronchiectasis: The long road to multidrug resistant bacteria
Menéndez, R., Sahuquillo-Arce, J. M., Méndez, R., & Hernández-Cabezas, A. (2016) · Community Acquired Infection · doi:10.4103/2225-6482.198491 · Cited by 5
Xu, Y., Yan, Z., & Liu, L. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-03453-4 · Cited by 4
Fungal microbiota in COPD patients during exacerbations
Gawor, W., Góralska, K., Galant, S., Majewski, S., Piotrowski, W. J., Miłkowska-Dymanowska, J., Kiszałkiewicz, J., & Brzeziańska‐Lasota, E. (2025) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2025.101543 · Cited by 4
Microbiota in the pathogenesis of COPD and its impact on the course of the disease
Fedotov, V. D., Zhestkov, A. V., Lyamin, A. V., Zaslavskaya, M. I., Сергеевна, Д. И., & TULICHEV, A. A. (2022) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2022.3.202-212 · Cited by 5
The role of lung microbiota in primary graft dysfunction in lung transplant recipients
Wu, Y., Huang, L., Li, M., Cui, X., Zhan, Q., & Wang, C. (2023) · Clinical Transplantation · doi:10.1111/ctr.15152 · Cited by 4
Fedoseev, G. B., Трофимов, В. И., Timchik, V. G., Negrutsa, K. V., Golubeva, V. I., Gorovneva, E. V., Razumovskaya, T. S., Birula, I. V., Alexandrin, V. A., & Kryakunov, K. N. (2015) · Russian Journal of Allergy · doi:10.36691/rja384 · Cited by 4
Microbiome in Chronic Lung Diseases
Mammen, M. J., & Sethi, S. (2017) · Barcelona Respiratory Network · doi:10.24875/brn.m17000010 · Cited by 4
Another piece in the ‘research mosaic’ that describes the role of the lung microbiome in COPD
Huffnagle, G. B. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207415 · Cited by 4
Sze, M. A., & Morris, A. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2329ed · Cited by 3
Why is it worth remembering the lung microbiome in ICU patients?
Siwicka-Gieroba, D., Barud, M., & Dąbrowski, W. (2021) · Anaesthesiology Intensive Therapy · doi:10.5114/ait.2021.108646 · Cited by 3
Impact of bacterial strain acquisition in the lung of patients with COPD: the AERIS study
Malvisi, L., Yarraguntla, A., Mortier, M.-C., Osman, K. L., Cleary, D. W., Sente, B., Pascal, T. G., Weynants, V. E., Clarke, S. C., Taddei, L., et al. (2022) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2022.2092648 · Cited by 3
Nanomedicine at the Pulmonary Frontier: Immune-Centric Approaches for Respiratory Disease Treatment
Kaur, J. K., Sharma, A., Passi, G., Dey, P., Khajuria, A., Alajangi, H. K., Jaiswal, P. K., Barnwal, R. P., & Singh, G. (2024) · Immunological Investigations · doi:10.1080/08820139.2023.2298398 · Cited by 3
Tiew, P. Y., & Chotirmall, S. H. (2024) · European Respiratory Society eBooks · doi:10.1183/2312508x.10006823 · Cited by 3
Haemophilus influenza e causes cellular trans-differentiation in human bronchial epithelia
Glöckner, M., Marwitz, S., Rohmann, K., Watz, H., Nitschkowski, D., Rupp, J., Dalhoff, K., Goldmann, T., & Drömann, D. (2021) · Innate Immunity · doi:10.1177/1753425921994906 · Cited by 3
A scoping review of longitudinal airway microbiota studies
Yin, T., Jeong, J. H., Hardcastle, T. F., Biswas, K., & Douglas, R. G. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1924061 · Cited by 3
Microbiome Based Diseases Diagnostics
Yadav, M., & Bhambi, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00012-7 · Cited by 3
Current status of microbiome research in asthma and chronic obstructive pulmonary disease
Kim, B., Rhee, C. K., Jung, J. Y., Kang, H., & Cho, S. (2016) · Allergy Asthma & Respiratory Disease · doi:10.4168/aard.2016.4.5.321 · Cited by 3
Butler, A. P., Smith, L., & Mackay, A. J. (2016) · European Respiratory Society eBooks · doi:10.1183/2312508x.10001416 · Cited by 3
Obermayer, A. (2018) · Journal of Immunological Sciences · doi:10.29245/2578-3009/2018/5.1161 · Cited by 2
Qiu, X., Bajinka, O., Wang, L., Wu, G., & Tan, Y. (2020) · doi:10.21203/rs.3.rs-17519/v1 · Cited by 3
The Effects of Corticosteroids on the Respiratory Microbiome: A Systematic ReviewPreprint
Hartmann, J. E., Albrich, W. C., Dmitrijeva, M., & Kahlert, C. R. (2020) · doi:10.21203/rs.3.rs-28779/v1 · Cited by 3
Huang, Y. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48552-4.00015-9 · Cited by 2
Zhang, L., He, X., Liu, J., Zhang, Y., Zuo, X., & Li, G. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106643 · Cited by 2
Nebulization of 2% lidocaine has no detectable impact on the healthy equine respiratory microbiota
Holley, L., Creasey, H. N., Bedenice, D., Reed, S. A., da Silva, D. R. R., Trautwein, V., Mazan, M. R., & Widmer, G. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316079 · Cited by 2
Cheng, Y.-N., Chen, G.-T., Huang, W., Chiu, Y.-P., Tang, Y., Fu, P., & Lee, T.-Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1706432 · Cited by 2
Moon, S. W., Kim, M., Kim, E. Y., Kang, C., Shin, J. H., Kim, K., Won, S., Yi, H., & Jung, J. Y. (2026) · Respiratory Research · doi:10.1186/s12931-025-03471-8 · Cited by 2
Microbiome therapeutics in respiratory illnesses
Yadav, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99336-4.00005-7 · Cited by 2
Oncogene-addicted solid tumors and microbiome—lung cancer as a main character: a narrative review
Guardamagna, M., Meyer, M., Berciano‐Guerrero, M., Mesas-Ruiz, A., Cobo, M., Pérez-Ruiz, E., Cantero, A., Lavado-Valenzuela, R., Barragán, I., Oliver, J., et al. (2024) · Translational Lung Cancer Research · doi:10.21037/tlcr-24-216 · Cited by 2
Venegas, C., Zhao, N., Ho, T., & Nair, P. (2020) · Tuberculosis and Respiratory Diseases · doi:10.4046/trd.2020.0033 · Cited by 2
Microbiome in Chronic Lung Diseases
Mammen, M. J., & Sethi, S. (2017) · Barcelona Respiratory Network · doi:10.23866/brnrev:2017-m0042 · Cited by 5
Provost, K. A., Frederick, C. A., & Sethi, S. (2017) · European Respiratory Society eBooks · doi:10.1183/2312508x.10016216 · Cited by 2
Qi, Y., Zhu, Z., Liu, X., Yang, J., Zhang, W., Huang, J., Li, H., Guan, W., Wang, Z., & Li, Y. (2022) · Medicine in Microecology · doi:10.1016/j.medmic.2022.100067 · Cited by 1
Hwang, D.-Y., An, M., Lee, P., Baek, A.-R., Park, S., Nam, Y., Lee, J.-H., Park, S.-W., Kim, D.-J., & Jang, A. (2025) · Letters in Applied Microbiology · doi:10.1093/lambio/ovaf089 · Cited by 1
The Airway Microbiome in Chronic Obstructive Pulmonary Disease (COPD): A Guide for Clinicians
Koo, W. L. Y., Thng, K. X., Tiew, P. Y., & Chotirmall, S. H. (2026) · British Journal of Hospital Medicine · doi:10.31083/bjhm50163 · Cited by 1
Li, N., Shen, A., Sun, X., Guo, Y., Yin, R., Qian, M., Zeng, F., Wang, H., Liu, X., Li, M., et al. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1740531 · Cited by 1
Wang, Y., Huang, Z., Zheng, J., Xu, O., Hong, Y., Ye, X., & He, Y. O. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1771765 · Cited by 1
Fedosenko, S. V., Karnaushkina, M. A., Ogorodova, L. M., Петров, В. А., Деев, И. А., Kulikov, E. S., & Сазонов, А. Э. (2016) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2016-5-159-165 · Cited by 1
Microbiome Therapeutics in Respiratory Illnesses
Shariff, M., & Aditi (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00002-4 · Cited by 1
Microbiome in Chronic Obstructive Pulmonary Disease (COPD)
Chandran, C. S., Subin, A. J., Raj, A., Swathy, K. K., & Raghunath, I. (2022) · Springer eBooks · doi:10.1007/978-981-16-8957-4_6 · Cited by 1
nicX-ing bad habits with your microbial friends
Upadhyay, V., & Turnbaugh, P. J. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00684-9 · Cited by 1
Exacerbations of chronic obstructive pulmonary disease
Авдеев, С. Н. (2024) · doi:10.18093/978-5-6048754-6-9-2024-2-198-209 · Cited by 1
Gonzales, G., Malka, R. E., Marinelli, L. M., Lee, C. M., Cook, S., Miar, S., Dion, G. R., & Guda, T. (2024) · Respiratory Research · doi:10.1186/s12931-024-02973-1 · Cited by 1
Nguyen, K. N., Daniel, S., Phillippi, D., Armstrong, T. D., Johnson, B., Ihemeremadu, W., & Lund, A. K. (2024) · Particle and Fibre Toxicology · doi:10.1186/s12989-024-00601-w · Cited by 1
Infections in the nose and exacerbations of chronic respiratory disorders
Xepapadaki, P. V., Megremis, S., Kitsioulis, N. A., & Papadopoulos, N. G. (2017) · European Respiratory Society eBooks · doi:10.1183/2312508x.10009916 · Cited by 1
The Respiratory Microbiome in COPD
O’Carroll, O., Peart, J., Mullen, E., & Burke, C. M. (2018) · InTech eBooks · doi:10.5772/intechopen.70776 · Cited by 1
Peripheral blood microbial signatures in COPDPreprint
Morrow, J. D., Castaldi, P. J., Chase, R., Yun, J. H., Lee, S., Liu, Y., Hersh, C. P., & the COPDGene Investigators (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.31.126367 · Cited by 1
Characteristics of Microbiome in Lung Adenocarcinoma Tissue from Patients in Southwestern ChinaPreprint
Zhu, S., Zhao, Y., Bao, Y., Cui, Y., Zhu, X., He, X., Ye, M., & Chen, X. (2020) · Research Square · doi:10.21203/rs.3.rs-46069/v1 · Cited by 1
Abotsi, R. E., Dube, F. S., Rehman, A. M., Claassen-Weitz, S., Xia, Y., Simms, V. M., Mwaikono, K. S., Gardner‐Lubbe, S., McHugh, G., Ngwira, L. G., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1386887/v1 · Cited by 1
Zinter, M. S., Dvorak, C. C., Mayday, M. Y., Reyes, G. A., Simon, M. R., Pearce, E. M., Kim, H., Shaw, P. J., Rowan, C. M., Auletta, J. J., et al. (2023) · medRxiv · doi:10.1101/2023.11.29.23299130 · Cited by 1
The Effect of Agricultural Exposures and Genetics on Respiratory Phenotypes
Boyd, L. W.-M. (2016) · DigitalCommons@UNMC
Quelle est la place de l’antibiothérapie ?
Gut‐Gobert, C. (2017) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2017.03.020
Ghimire, A., & Han, M. K. (2018) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2018.03.008
Karnaushkina, M. A., Fedosenko, S. V., Сазонов, А. Э., Петров, В. А., Ovsyannikov, D. Y., & Ogorodova, L. M. (2018) · Современные технологии в медицине · doi:10.17691/stm2018.10.2.11
The lung microbiome in obstructive airways disease: potential pathogenetic roles
Chung, K. F., Huffnagle, G. B., & Huang, Y. J. (2019) · European Respiratory Society eBooks · doi:10.1183/2312508x.10016118
Compromised immunity and the microbiome: transplantation, cancer and HIV
Bernasconi, E., Aubert, J., Koutsokera, A., Nicod, L. P., & Twigg, H. L. (2019) · European Respiratory Society eBooks · doi:10.1183/2312508x.10031818
THE MICROBIOTA OF LOWER AIRWAYS IN PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASES
Александровна, М. С., Danilina, G. А., Smirnova, M. Y., Osipova, G. L., Gervazieva, V. B., Konischeva, A. Y., & Оspelnikova, Т. P. (2018) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-2018-5-53-60
Lee, S. Y. (2020) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/136835
Chang, K., Zou, X., Li, Z., Yang, Z., Gao, J., Yang, G., Zhang, Y., Li, X., Zhang, X., Liu, Y., et al. (2020) · doi:10.21203/rs.3.rs-103624/v1
The lung microbiome in end-stage Lymphangioleiomyomatosis
Ng, J., Pacheco–Rodriguez, G., Begley, L., Huang, Y. J., Poli, S., Perrella, M. A., Rosas, I. O., Moss, J., & El‐Chemaly, S. (2021) · Respiratory Research · doi:10.1186/s12931-021-01873-y
Kolla, H. B., Reddy, P. N., & Bramhachari, P. V. (2021) · Springer eBooks · doi:10.1007/978-981-16-3156-6_7
Sulaiman, I., Tsay, J.-C. J., & Segal, L. N. (2022) · Respiratory medicine · doi:10.1007/978-3-030-87104-8_8
The Respiratory Microbiome in Health and Disease
Invernizzi, R., & Molyneaux, P. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00196-7
Rhoades, N. S., Davies, M., Lewis, S. A., Cinco, I. R., Kohama, S. G., Bermudez, L. E., Winthrop, K. L., Fuss, C., Mattison, J. A., Spindel, E. R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.08.479578
Serisier, D. J. (2015) · European Respiratory Society eBooks · doi:10.1183/2312508x.10018814
Bacterial Colonization in COPD
Donnelly, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00242-0
Infective Exacerbations of Chronic Lung Disease
Mallia, P., Coultas, J. A., & Cafferkey, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00138-4
Ghimire, A., & Han, M. K. (2019) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2018.03.012
Nisar, A., Kathade, S. A., Aswani, M. A., Harsulkar, A., Jagtap, S., & Kunchiraman, B. N. (2022) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/2992
A Compendium of Chronic Obstructive Pulmonary Disease
Ong, K. C. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102180
Lee, H. J., Jin, K. N., Lee, H. W., Lee, J., Park, T. Y., Heo, E. Y., & Kim, D. K. (2022) · International Journal of COPD · doi:10.2147/copd.s372735
Metadata
- Authors
- Huang, Y. J., Sethi, S., Murphy, T., Nariya, S., Boushey, H. A., & Lynch, S. V.
- Affiliations
- University of California, San Francisco (US)
- Buffalo VA Medical Center (US)
- University at Buffalo, State University of New York (US)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2014-08
- Volume
- 52
- Issue
- 8
- Pages
- 2813-2823
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC4136157
- OpenAlex
- W2135623379
- Cited by
- 323
- References
- 48
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 25 · 2023: 25 · 2022: 30 · 2021: 33 · 2020: 35 · 2019: 28 · 2018: 24 · 2017: 38 · 2016: 27 · 2015: 29 · 2014: 6
- FWCI
- 26.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23HL105572, HL105572)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- chronic obstructive pulmonary disease, COPD exacerbations, airway microbiome, sputum microbiota, Proteobacteria, antibiotic therapy, oral corticosteroids, inflammation
- MeSH terms
- Aged, Aged, 80 and over, DNA, Bacterial, DNA, Ribosomal, Humans, Longitudinal Studies, Male, Middle Aged, Phylogeny, Respiratory System, RNA, Ribosomal, 16S, Sputum, Cluster Analysis, Sequence Analysis, DNA, Proteobacteria, Pulmonary Disease, Chronic Obstructive, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review